Sponsored Ad | Moonfare - Leaderboard

China market regulator fines two pharma firms for monopoly behaviour

China market regulator fines two pharma firms for monopoly behaviour

Photo: Unsplash

28 May, 2023

Grand Pharmaceutical Wuhan Healcare Pharmaceuticals

Printed by Unregistered user on Tue, 04 Nov 2025 09:58:51 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Policy & Regulations

China regulator asks Futu and UP Fintech to stop soliciting mainland clients

Policy & Regulations

China regulator probes banks' property loan portfolio to assess systemic risks

Read more from Greater China

People Digest: Equirus ropes in industry veteran; FTAHK appoints CEO

Policy & Regulations

China to support mainland investors to trade HK-listed stocks in yuan